{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:45:20Z","timestamp":1791089120543,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T00:00:00Z","timestamp":1241481600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000432","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T22:33:26Z","timestamp":1241476406000},"page":"e432","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study"],"prefix":"10.1371","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct00703924","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Afif","family":"Ben Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A.","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Morizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ben Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amor","family":"Z\u00e2atour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissaf","family":"Ben Alaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil Bel","family":"Haj Hamida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher El","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koussay","family":"Dellagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Gr\u00f6gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,5,5]]},"reference":[{"key":"ref1","first-page":"267","article-title":"Human leishmaniases: epidemiology and public health aspects.","volume":"45","author":"P Desjeux","year":"1992","journal-title":"World Health Stat Q"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.idc.2004.11.005","article-title":"Cutaneous leishmaniasis in the returning traveler.","volume":"19","author":"AJ Magill","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers.","volume":"53","author":"J Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref4","first-page":"503","article-title":"[Treatment of localized cutaneous leishmaniasis].","volume":"121","author":"P Buffet","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0035-9203(86)90176-8","article-title":"Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria [letter].","volume":"80","author":"S Belazzoug","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","article-title":"Current treatment approaches to leishmaniasis.","volume":"16","author":"J Berman","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"ref7","first-page":"847","article-title":"Therapy in man.","author":"A Bryceson","year":"1987"},{"key":"ref8","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis.","volume":"3","author":"T Garnier","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.","volume":"97","author":"A Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.","volume":"2","author":"PJ Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01964420","article-title":"Intracellular distribution and activity of antibiotics.","volume":"10","author":"PM Tulkens","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.26.5.745","article-title":"Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.","volume":"26","author":"J El-On","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.","volume":"27","author":"J el-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/1523-1747.ep12696697","article-title":"Topical treatment of cutaneous leishmaniasis.","volume":"87","author":"J El-On","year":"1986","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.","volume":"65","author":"BA Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(94)90517-7","article-title":"Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.","volume":"88","author":"G Krause","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.","volume":"91","author":"RX Armijos","year":"2004","journal-title":"Acta Trop"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.","volume":"53","author":"A Asilian","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.","volume":"53","author":"A Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.","volume":"99","author":"F Iraji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.","volume":"85","author":"M Grogl","year":"1999","journal-title":"J Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL\/6 Model.","volume":"1","author":"H Lecoeur","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.","volume":"66","author":"JM Soto","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","first-page":"769","article-title":"[Numerical cladistics of the phylogeny of the genus Leishmania Ross, 1903 (Kinetoplastida-Trypanosomatidae). Use of enzyme characteristics].","volume":"299","author":"G Lanotte","year":"1984","journal-title":"C R Acad Sci III"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-3156.1999.00487.x","article-title":"Diagnostic PCR with Leishmania donovani specificity.","volume":"4","author":"M Boelaert","year":"1999","journal-title":"Trop Med Int Health"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure.","volume":"359","author":"P Trouiller","year":"2002","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India.","volume":"356","author":"S Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/35.5.577","article-title":"The sensitivity of Leishmania species to aminosidine.","volume":"35","author":"RA Neal","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.","volume":"36","author":"O Ozgoztasi","year":"1997","journal-title":"Int J Dermatol"},{"key":"ref30","first-page":"289","article-title":"Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994\u201395.","volume":"76","author":"I Sharifi","year":"1998","journal-title":"Bull World Health Organ"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jama.281.4.361","article-title":"Access to essential drugs in poor countries: a lost battle?","volume":"281","author":"B Pecoul","year":"1999","journal-title":"Jama"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30058-5","article-title":"Epidemiology of the leishmaniases.","volume":"13","author":"AJ Magill","year":"1995","journal-title":"Dermatol Clin"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014047","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:25:35Z","timestamp":1589041535000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000432"}},"subtitle":[],"editor":[{"given":"Diana N. J.","family":"Lockwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,5,5]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000432","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,5]]}}}